StressGen jumps 18% on virus test results
Article Abstract:
Victoria, BC-based StressGen Biotechnologies Corp. announced that it achieved positive results from clinical tests of a drug that will be used to treat a common sexually transmitted diseases. StressGen's share price rose 18% on news of the breakthrough.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Adherex makes plans to market IPO
Article Abstract:
Adherex Technologies Inc., which is a drug development company, has announced plans to launch a $20 million initial public offering. Adherex is developing a new anti-cancer drug, called Exherin, that is designed to reduce blood vessels that feed tumors.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Labopharm feels market pain from delayed approval of new drug
Article Abstract:
Effects of delay in approval of new pain-killing drug by United States Food and Drug Administration, on stock prices of Labopharm Incorporated, are described.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Sears fails to gain much ground with lackluster profit report. Bay, Zellers shoppers to be wooed in 'cross-shopping' plan
- Abstracts: Award-winning Shift magazine awaits fate after finances dry up. U.S. drug officials vetted TV shows' plot lines
- Abstracts: Canadians red-faced as Russians make a farce of bankruptcy law. Recovering Russia lures investor group